These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 38423898)

  • 1. Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors.
    Mashayekhi M; Safa BI; Gonzalez MSC; Kim SF; Echouffo-Tcheugui JB
    Trends Endocrinol Metab; 2024 May; 35(5):425-438. PubMed ID: 38423898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement.
    Alsereidi FR; Khashim Z; Marzook H; Gupta A; Al-Rawi AM; Ramadan MM; Saleh MA
    Curr Probl Cardiol; 2024 May; 49(5):102524. PubMed ID: 38492622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review regarding the article 'Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement'.
    He X; Yuan D
    Curr Probl Cardiol; 2024 Jun; 49(6):102563. PubMed ID: 38599557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease.
    Bonnet F; Scheen AJ
    Diabetes Metab; 2018 Dec; 44(6):457-464. PubMed ID: 30266577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics.
    Packer M
    Am J Kidney Dis; 2021 Feb; 77(2):280-286. PubMed ID: 32711072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium-glucose Cotransporter 2 Inhibitors and Pathological Myocardial Hypertrophy.
    Gao Z; Bao J; Hu Y; Tu J; Ye L; Wang L
    Curr Drug Targets; 2023; 24(13):1009-1022. PubMed ID: 37691190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?
    Elrakaybi A; Laubner K; Zhou Q; Hug MJ; Seufert J
    Mol Metab; 2022 Oct; 64():101549. PubMed ID: 35863639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and Cardiac Implications of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors: The State of the Science.
    Cruz JE; Ahuja T; Bridgeman MB
    Ann Pharmacother; 2018 Dec; 52(12):1238-1249. PubMed ID: 29911393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents.
    Theofilis P; Sagris M; Oikonomou E; Antonopoulos AS; Siasos G; Tsioufis K; Tousoulis D
    Int Immunopharmacol; 2022 Oct; 111():109080. PubMed ID: 35908505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials.
    Lee MMY; Petrie MC; McMurray JJV; Sattar N
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):506-522. PubMed ID: 31996025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors.
    Dabravolski SA; Zhuravlev AD; Kartuesov AG; Borisov EE; Sukhorukov VN; Orekhov AN
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction.
    Liu B; Wang Y; Zhang Y; Yan B
    Curr Top Med Chem; 2019; 19(20):1818-1849. PubMed ID: 31456521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes.
    Čertíková Chábová V; Zakiyanov O
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease.
    Bellanti F; Lo Buglio A; Dobrakowski M; Kasperczyk A; Kasperczyk S; Aich P; Singh SP; Serviddio G; Vendemiale G
    World J Gastroenterol; 2022 Jul; 28(26):3243-3257. PubMed ID: 36051336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.
    Perry RJ; Shulman GI
    J Biol Chem; 2020 Oct; 295(42):14379-14390. PubMed ID: 32796035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory Effects of SGLT2 Inhibitors-Targeting Inflammation and Oxidative Stress in Aging.
    Schönberger E; Mihaljević V; Steiner K; Šarić S; Kurevija T; Majnarić LT; Bilić Ćurčić I; Canecki-Varžić S
    Int J Environ Res Public Health; 2023 Aug; 20(17):. PubMed ID: 37681811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
    Packer M
    J Am Soc Nephrol; 2020 May; 31(5):907-919. PubMed ID: 32276962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors.
    Mordi IR; Lang CC
    Heart Fail Clin; 2022 Oct; 18(4):529-538. PubMed ID: 36216483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease.
    Milder TY; Stocker SL; Samocha-Bonet D; Day RO; Greenfield JR
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1481-1490. PubMed ID: 31377891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effect of SGLT2 Inhibitors.
    Pawlos A; Broncel M; Woźniak E; Gorzelak-Pabiś P
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.